BPC Spray

What it is?

BPC Spray is a topical delivery format of BPC-157 designed for localised application. It is positioned for protocols where convenience, targeted exposure, and non-injectable delivery are preferred, while maintaining a recovery-focused signalling profile.

Dripfy Advantage

• Localised delivery strategy: Supports targeted application to specific areas, aligning with protocols where local outcomes are monitored.
• Non-injectable compliance: Designed for users and settings where injectable administration is not optimal, improving routine adherence.
• Barrier and repair signalling: Positioned for tissue repair pathways relevant to wound recovery and inflammation balance in topical protocols.
• Convenience for consistent use: Spray format supports frequent, structured application, often critical for local recovery routines.

Clinical Applications & Therapeutic Potential

• Local injury support: Potential support for localised discomfort and inflammation-associated markers in minor injury contexts.
• Wound healing pathways: Positioned for skin and surface-level repair signalling and recovery endpoints.
• Inflammation modulation: Potential reductions in local inflammatory response markers with improved recovery comfort.
• Injection-avoidant protocols: A practical option where non-invasive delivery is a requirement for the protocol design.

Composition & Formulation

• Active peptide: BPC-157 (synthetic pentadecapeptide)
• Formulation: Intranasal spray (aqueous buffered solution; preservative-controlled)